کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4171140 1275649 2011 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Treatment of paediatric TB: revised WHO guidelines
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پریناتولوژی (پزشکی مادر و جنین)، طب اطفال و بهداشت کودک
پیش نمایش صفحه اول مقاله
Treatment of paediatric TB: revised WHO guidelines
چکیده انگلیسی

SummaryThe World Health Organization has recently revised the recommended dosages of the main first-line anti-tuberculosis drugs for use in children. The recommended dosages and range of isoniazid, rifampicin, pyrazinamide and ethambutol have been increased from the previous recommended dosages. Ethambutol is now recommended for use in children of all ages including those of less than 5 years of age. This review explains the rationale for these recent revisions. Children require higher dosages than adults to achieve the same serum concentrations. Available data in HIV-uninfected children suggest that the revised dosages are within limits that have a very low risk of toxicity. An important challenge will be to examine the impact of higher dosages on clinical response, drug-drug interactions and risk of toxicity in HIV-infected children.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Paediatric Respiratory Reviews - Volume 12, Issue 1, March 2011, Pages 22–26
نویسندگان
,